NCT04996979

Brief Summary

Hip fracture pain is often severe and traditionally managed by systemic opioids which have increased risk of side effects in frail elderly patients. Inadequately controlled pain may lead to delirium which increases mortality and morbidity. The overall aim of this RCT is to investigate the potential for improved pain relief accomplished by the addition of the PENG block to current standard practice of pre-operative analgesia (systemic morphine), compared to the control group, which involves no block (operator will still go through the motion as if performing a block) plus standard pre-operative analgesia. The investigator hypothesize that the addition of a single shot PENG block at the side of hip fracture in addition to traditional systemic morphine provides good preoperative pain relief on movement and reduces the need for breakthrough opioid requirements. The investigator hypothesize that the interventional group dynamic pain score assessed at 30 minutes after the block compared to control group dynamic pain score at 30 minutes after the "block" will be at least a 3 point difference between the 2 groups .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2021

Completed
14 days until next milestone

Study Start

First participant enrolled

May 24, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 9, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

August 9, 2021

Status Verified

August 1, 2021

Enrollment Period

1 year

First QC Date

May 10, 2021

Last Update Submit

August 2, 2021

Conditions

Keywords

Hip fractures, elderly, pain

Outcome Measures

Primary Outcomes (1)

  • Dynamic pain scores (Numerical pain score (NRS) at 15 degrees leg lift)

    The difference in dynamic pain scores (NRS at 15 degrees leg lift) at 30 minutes post block performance in the intervention group vs the control group. Assessment of the dynamic pain score is done prior to discharge from recovery at SGH Pain Management Centre.

    30 minutes after receiving intervention

Secondary Outcomes (3)

  • Pain scores (NRS) at rest (static pain) and on movement (dynamic pain)

    Up to 24 hours from performance of block

  • Pain scores collected to estimate the onset and duration of block Pain scores to estimate the onset and duration of block

    Up to 24 hours from performance of block

  • Total opioid use over 24 hours as a surrogate measure

    Up to 24 hours from performance of block

Study Arms (2)

Control

PLACEBO COMPARATOR

Only standard care

Drug: Placebo

Intervention group

EXPERIMENTAL

The PENG block was performed for intervention group with local anaesthetic solution composed of 20 ml of ropivacaine 0.5%.

Drug: Ropivacaine 0.5% Injectable Solution

Interventions

Local anaesthetic solution composed of ropivacaine 0.5%(intervention group)

Intervention group

Standard care

Also known as: Standard care
Control

Eligibility Criteria

Age60 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 60 years old and above
  • Provided consent for the study
  • Patients with solitary hip fracture (no other fracture) - intracapsular neck of femur fracture, intertrochanteric fracture
  • Either awaiting hip fracture surgery or no plans for hip fracture surgery within the next 24 hours

You may not qualify if:

  • Patients with cognitive impairment or inability to give consent, or refusal to give consent
  • Multiple fracture cases
  • Peri-prosthetic fractures and revisions
  • Subclinical vertebral fractures
  • Hip fractures due to major accidents such as road traffic accidents, fall from height or more than 2 meters
  • Multiple trauma
  • Pathological fractures secondary to metastases
  • Patients with contraindications to block performance
  • Coagulopathy as demonstrated by PT/PTT/INR
  • On antiplatelets or anticoagulation
  • Infection/ compromised skin integrity at site of block performance
  • Allergy to local anaesthetics and opioids

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pain Management Center Sinagpore General Hospital

Singapore, 169608, Singapore

RECRUITING

Related Publications (3)

  • Tay E. Hip fractures in the elderly: operative versus nonoperative management. Singapore Med J. 2016 Apr;57(4):178-81. doi: 10.11622/smedj.2016071.

  • Giron-Arango L, Peng PWH, Chin KJ, Brull R, Perlas A. Pericapsular Nerve Group (PENG) Block for Hip Fracture. Reg Anesth Pain Med. 2018 Nov;43(8):859-863. doi: 10.1097/AAP.0000000000000847.

  • Lin X, Liu CW, Goh QY, Sim EY, Chan SKT, Lim ZW, Chan DXH. Pericapsular nerve group (PENG) block for early pain management of elderly patients with hip fracture: a single-center double-blind randomized controlled trial. Reg Anesth Pain Med. 2023 Nov;48(11):535-539. doi: 10.1136/rapm-2022-104117. Epub 2023 Apr 13.

Related Links

MeSH Terms

Conditions

Hip FracturesPain

Interventions

RopivacaineStandard of Care

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Patient, nurses and CRC will be blinded. Rest of study team is not blinded.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 10, 2021

First Posted

August 9, 2021

Study Start

May 24, 2021

Primary Completion

May 31, 2022

Study Completion

December 31, 2022

Last Updated

August 9, 2021

Record last verified: 2021-08

Locations